Demo
Close Language Tab
Locate us
Languages
K
Krebs Biochemicals & Industries Ltd Pharmaceuticals
₹ 76.79 -1.60 (-2.04%)
  • NSE
  • BSE

Overview

  • BSE Code 524518
  • NSE Symbol KREBSBIO
  • ISIN Demat INE268B01013
  • Book Value (₹) -67.83
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 176.80
  • P/E (TTM) 0.00
  • EPS (TTM) 0.00
  • Div Yield (%) 0.00

Performance

Today’s Low 76.70
Today’s High 78.79

76.79
52W Low 66.12
52W High 129.07

76.79
Open 77.00
Prev. Close 78.39
Volume 3,168.00

Corporate Actions

Krebs Biochemicals and Industries Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Apr 02, 2025

The Company has enclosed herewith certificate received from RTA under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.03.2025

Krebs Biochemicals and Industries Limited - Disclosure under SEBI Takeover Regulations
Apr 01, 2025

Harish Kamath has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

About Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd[KBIL](Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.

KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994.

KBIL since inception, has adopted global agenda for its growth by strategic emphasising on its specific area of expetise "Fermentation Technology". During 2001-02, the company has successfully formally introduced Vitamin C(I P Grade) through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing Lovastatin,Simvastatin and Vitamin-C.

The company is now in the process of installing a co-generation power plant at Unit-II. As a step in the direction of backward integration and to capitalise on co-generation and Ethanol manufacturing the company has successfully bidded and executed a strategic acquisition of the Nannapaneni Venkatrao Co-operative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28, 2003.

Founded: 1991
Chairman: R T Ravi
Managing Director: Jitendra Shah
Address: Kothapalli(V) Kasimkota(M), Anakapalli, Vishakapatnam, Andhra Pradesh, 531031,
HO Tel: 91-040-66808040